Autres langues Bio-Techne Corporation

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 10/05/2024			Varia. 5j.	Varia. 1 janv.
80,91 ^USD	+1,71 %		+4,68 %	+4,86 %

06/05	BIO-TECHNE CORPORATION : Argus reste à l'achat	ZM
02/05	BIO-TECHNE CORPORATION : UBS reste à l'achat	ZM

BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024	08/05
Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	01/05
Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	01/05
Top Midday Gainers	01/05
US Equity Indexes Mixed as Investors Look for Clarity in Fed's Policy Path in Presidential Election Year	01/05
US Equity Indexes Mixed Ahead of Fed Policy Statement, Views on Monetary Policy Path for 2024	01/05
Bio-Techne Shares Jump After Fiscal Q3 Beat	01/05
Bio-Techne's Fiscal Q3 Adjusted Earnings Fall, Net Sales Rise	01/05
Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q3 Revenue $303.4M	01/05
BIO-TECHNE DECLARES DIVIDEND	01/05
BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS	01/05
Bio-Techne Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	01/05
Bio-Techne Corporation Declares Dividend for the Quarter Ended March 31, 2024, Payable on May 24, 2024	01/05
BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS	30/04
Bio-Techne Corporation Appoints Dr. Judith Klimovsky to Board of Directors	30/04
Bio-Techne to Enter Product Distribution Deal With Thermo Fisher Scientific	29/04
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC	29/04
Bio-Techne Corporation Announces New Distribution Agreement with Thermo Fisher Scientific	29/04
BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY	26/04
Bio-Techne Corporation and Novomol-Dx Announce Point-of-Care Ocular Biomarker Assay	26/04

Aucun résultat pour cette recherche